MICAFUNGIN

Peak

micafungin sodium

NDAINTRAVENOUSPOWDER
Approved
Jul 2021
Lifecycle
Peak
Competitive Pressure
30/100
Clinical Trials
20

Clinical Trials (5)

NCT03102658Phase 4Completed

Micafungin Pharmacokinetics in Obese Patients

Started Jan 2017
24 enrolled
Morbid Obesity
NCT02440178Phase 2Completed

Micafungin Prophylaxis During 1st Induction Chemotherapy for De Novo Acute Leukemia

Started Sep 2015
66 enrolled
Acute Leukemia
NCT03421002Phase 2Completed

Determination of Levels of Micafungin in Neonates Suffering From Systemic Candidiasis and/or Candida Meningitis

Started May 2015
35 enrolled
Candidiasis, SystemicCandida Meningitis
NCT02678598N/ACompleted

A Retrospective Study Evaluating the Efficacy and Safety of Micafungin Sodium in the Treatment of Invasive Fungal Infections

Started Mar 2015
2,555 enrolled
Invasive Fungal Infections
NCT02127788N/ACompleted

Use of Micafungin (Mycamine®) as Antifungal Prophylaxis in Haematology and Onco-haematology

Started Jul 2014
150 enrolled
Antifungal ProphylaxisHaemopathy